Drug
Drl RI
Drl RI: highest development phase Phase 3, developed by Dr. Reddy's. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Dr. Reddy's
Trials
| Drug | Phase | Indication |
|---|---|---|
| DRL_RI (Proposed rituximab biosimilar) NCT03976102 | Phase 3 | Follicular Lymphoma |
Latest
No recent events.
Follow Drl RI on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.